NCT03367572 2025-09-25
Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer
University of Rochester
Phase 3 Completed
Clinical Trials
6 trialsNCT03040726 2023-10-17
Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer
M.D. Anderson Cancer Center
Phase 2/3 Completed
NCT04669132 2022-02-23
OLNEPA
Instituto Brasileiro de Controle do Cancer
Phase 2 Completed
NCT03097588 2021-07-12
Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant
OHSU Knight Cancer Institute
Phase 2 Completed
NCT04201769 2020-04-03
LUNG-NEPA
Consorzio Oncotech
Phase 3 Unknown
NCT03862144 2019-03-05
GIM15-NEPA
Consorzio Oncotech
Phase 2 Completed